Glucocorticoid Receptor-Targeted Liposomal Codelivery of Lipophilic Drug and Anti-Hsp90 Gene: Strategy to Induce Drug-Sensitivity, EMT-Reversal, and Reduced Malignancy in Aggressive Tumors
Molecular Pharmaceutics | May 17, 2016 | Volume: 13 | Issue: 7 | Pages: 2507-2523
10.1021/acs.molpharmaceut.6b00230
| PMID 27184196